LANIA, Andrea Gerardo Antonio
 Distribuzione geografica
Continente #
NA - Nord America 9.104
AS - Asia 5.601
EU - Europa 1.929
SA - Sud America 1.228
AF - Africa 275
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.155
Nazione #
US - Stati Uniti d'America 8.939
SG - Singapore 3.721
BR - Brasile 1.012
CN - Cina 805
VN - Vietnam 485
IT - Italia 385
FI - Finlandia 347
IE - Irlanda 240
DE - Germania 209
NG - Nigeria 191
FR - Francia 163
GB - Regno Unito 130
HK - Hong Kong 126
NL - Olanda 115
AR - Argentina 95
IN - India 91
CA - Canada 88
BD - Bangladesh 80
RU - Federazione Russa 58
SE - Svezia 51
MX - Messico 45
IQ - Iraq 36
PK - Pakistan 36
UA - Ucraina 32
PL - Polonia 31
CO - Colombia 27
ID - Indonesia 26
TR - Turchia 26
EC - Ecuador 25
JP - Giappone 25
ZA - Sudafrica 25
ES - Italia 24
PH - Filippine 22
AT - Austria 21
MK - Macedonia 21
CL - Cile 18
PY - Paraguay 17
BE - Belgio 16
VE - Venezuela 16
IL - Israele 15
SA - Arabia Saudita 14
UZ - Uzbekistan 14
AU - Australia 11
KE - Kenya 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
LT - Lituania 10
RO - Romania 10
AL - Albania 8
DZ - Algeria 8
HU - Ungheria 8
MY - Malesia 8
IR - Iran 7
MA - Marocco 7
NP - Nepal 7
PE - Perù 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
GE - Georgia 6
KR - Corea 6
LV - Lettonia 6
CI - Costa d'Avorio 5
GR - Grecia 5
JM - Giamaica 5
OM - Oman 5
SN - Senegal 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
EG - Egitto 4
GT - Guatemala 4
KZ - Kazakistan 4
NI - Nicaragua 4
NO - Norvegia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EE - Estonia 3
HN - Honduras 3
LB - Libano 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
TH - Thailandia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 18.135
Città #
Singapore 1.594
Chandler 1.207
Wilmington 1.051
Dallas 782
Ashburn 620
The Dalles 515
San Mateo 402
San Jose 395
Shanghai 388
Helsinki 347
Ann Arbor 337
New York 329
Dublin 239
Boardman 208
Lawrence 204
Princeton 204
Benin City 191
Leawood 179
Ho Chi Minh City 170
Beijing 163
Milan 143
Paris 131
Hanoi 121
Hong Kong 120
Los Angeles 120
Fairfield 87
São Paulo 84
Santa Clara 83
Woodbridge 82
Amsterdam 74
Buffalo 66
London 58
Seattle 37
Pune 35
Rome 34
Rio de Janeiro 33
Brooklyn 32
Falkenstein 30
Orem 28
Naples 27
Montreal 26
Da Nang 25
Toronto 24
Council Bluffs 23
Lahore 23
Warsaw 23
Belo Horizonte 22
Norwalk 22
Phoenix 22
Tokyo 22
Haiphong 21
Assago 20
Munich 20
Buenos Aires 19
Curitiba 19
Chicago 18
Frankfurt am Main 18
San Diego 18
Porto Alegre 17
Atlanta 16
Brussels 16
Campinas 16
Charlotte 16
Columbus 16
Dhaka 15
Mumbai 15
Johannesburg 14
Mexico City 14
San Francisco 14
Manchester 13
Fortaleza 12
Hải Dương 12
Tashkent 12
Boston 11
Goiânia 11
Recife 11
Chennai 10
Poplar 10
Abbiategrasso 9
Bogotá 9
Guarulhos 9
Houston 9
Kocaeli 9
Pasadena 9
Salvador 9
Skopje 9
Stockholm 9
Uberlândia 9
Baghdad 8
Biên Hòa 8
Campo Grande 8
Guayaquil 8
Nairobi 8
Natal 8
Quito 8
Ribeirão Preto 8
Asunción 7
Brasília 7
City of London 7
Madrid 7
Totale 11.788
Nome #
CLINICAL PRESENTATION OF BONE METASTASES IN NEUROENDOCRINE TUMORS: A RETROSPECTIVE COHORT STUDY 374
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 211
Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry 197
Safety of Romosozumab in women with cancer and osteoporosis at high risk of fractures 182
A 2019 update on TSH-secreting pituitary adenomas 129
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 126
Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fractures 119
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 110
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 107
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 103
G protein mutations in endocrine diseases 101
Adequacy of current postglucose GH nadir limit (< 1 mu g/1) to define long-lasting remission of acromegalic disease 101
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal 101
Central hypothyroidism and growth hormone treatment : clinical care 100
Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation 100
An Unusual Case of Recurrent Autoimmune Hypophysitis 99
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 98
Activating mutations of the G(s)alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors 97
Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective study 97
G-Protein and Signalling in Pituitary Tumours 96
A potential catastrophic trap: an unusually presenting sellar lesion 95
[18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results 95
Parental origin of G(s)alpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors 94
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors 94
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 94
G protein abnormalities in pituitary adenomas 93
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients 92
A Multicenter Cohort Study in Patients With Primary Empty Sella: Hormonal and Neuroradiological Features Over a Long Follow-Up 90
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype 88
Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation 88
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management 88
Could low prolactin levels after radiotherapy predict the onset of hypopituitarism? 87
Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms 87
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 86
The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk 86
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 86
Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior 86
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 85
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 84
A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells 84
Growth factors and human pituitary adenomas 82
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 82
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 81
Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas 81
Functional hypothalamic and drug-induced amenorrhea: an overview 81
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma 81
Hormonal signaling and pituitary adenomas 80
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 80
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 80
Pancreatic Neuroendocrine Tumours: The Role of Endoscopic Ultrasound Biopsy in Diagnosis and Grading Based on the WHO 2017 Classification 80
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment 80
Filamin-A Is Essential for Dopamine D2 Receptor Expression and Signaling in Tumorous Lactotrophs 79
Complete Remission of Hepatic Metastasis after Total Gastrectomy for a Gastric Carcinoid Tumor Type 1: A Case Report 78
Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome 77
Bone disorders associated with acromegaly: mechanisms and treatment 77
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 76
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 76
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 76
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 76
Expression of the anti-apoptotic factor seladin-1 and induction of apoptosis in GH secreting adenomas and in non-functioning pituitary adenomas 76
Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients 76
A practical use of bone turnover markers in management of patients with skeletal fragility 75
Central hypothyroidism - a neglected thyroid disorder 75
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia 75
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues 74
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures. 74
Effect of cyclic adenosine 3 ',5 '-monophosphate/protein kinase A pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 74
Is the 250 mu g ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? 74
GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency 74
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 74
Thyrotoxicosis in patients with COVID-19: the THYRCOV study 74
[Genetic changes in human pituitary adenomas] 74
cAMP in the pituitary: An old messenger for multiple signals 73
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident 73
Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation 73
Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression 73
Dopamine D-2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas 73
Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas 72
GNAS imprinting and pituitary tumors 72
Genetics of pituitary tumors: Focus on G-protein mutations 72
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly 72
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 72
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 72
Inactivating and activating mutations of the Gs alpha gene 72
Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients 72
Levothyroxine supplementation on assisted reproduction technology (ART) outcomes in women with subtle hypothyroidism: a retrospective study 72
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 72
Bilateral testicular masses and adrenal insufficiency: is congenital adrenal hyperplasia the only possible diagnosis? First two cases of TARTS described in Addison-only X-linked adrenoleukodystrophy and a brief review of literature 72
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 72
COVID-19 vaccines and blood glucose control: Friend or foe? 71
Biallelic expression of the Gs alpha gene in human bone and adipose tissue 71
Focus on GH deficiency and thyroid function 71
Pituitary incidentalomas 70
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 70
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 70
Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19 70
Late-onset Schmidt's Syndrome Presenting with Severe Hyponatremia: A Case Report 69
Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas 69
cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion 69
Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study 69
Totale 8.900
Categoria #
all - tutte 123.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021197 0 0 0 0 0 0 0 0 0 0 0 197
2021/20221.008 31 5 7 226 7 8 32 132 143 115 237 65
2022/20233.127 448 141 308 348 287 268 25 253 536 291 178 44
2023/20241.821 122 203 333 112 44 269 103 105 48 28 185 269
2024/20253.066 66 37 64 64 53 296 236 327 427 673 421 402
2025/20267.541 997 409 868 825 233 278 1.983 374 347 409 354 464
Totale 18.395